SAN DIEGO, March 28, 2017 /PRNewswire/ -- Prometheus Laboratories Inc.—a Nestlé Health Science company—announces the launch of IBcause™, an all-in-one convenient test that evaluates a unique ...

Bayer has linked up with Prometheus Laboratories which will see the US firm develop diagnostic tools and personalise treatments in the former’s oncology pipeline. Bayer has linked up with Prometheus ...

Collaboration focused on stratifying patients to appropriate targeted therapies and accelerating drug development SAN DIEGO, March 17 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty ...

Firm’s newly established business will use purchase to move into gastrointestinal testing. Nestlé’s recently established Nestlé Health Science operation will acquire specialty pharmaceutical and ...

SAN DIEGO, Oct. 15-- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc ...

On Friday, December 17, 2010, the United States Court of Appeals for the Federal Circuit issued a decision in one of the patentable subject matter cases that was returned to the Court by the Supreme ...

Data will also be presented from independent studies of PROLEUKIN® (aldesleukin), a recombinant human interleukin-2 for treatment in adults with metastatic melanoma and metastatic renal cell carcinoma ...